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FIGURE 1 Trends in E-Consults, Visits, and Expected Visits Before and After Intervention
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Tracking the number and types of referrals, as well expected cardiac evaluations, from October 2013 through May 2014.
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2707To enhance value, an e-consult program in car-
diology needs to provide both high-quality provi-
der and patient satisfaction. In a preliminary pilot
study, we have shown that offering an e-consult
option in cardiology does not appear to increase
overall total referral volume, with referring pro-
viders requesting e-consults in lieu of traditional
visits. Furthermore, e-consults appear to be associ-
ated with high rates of satisfaction among both
providers and patients.
These preliminary ﬁndings from a single center
should be interpreted with caution. A more deﬁnitive
study would involve multiple sites; track visit vol-
umes, total costs, and patient outcomes over a longer
time period; and assess patient and physician expe-
rience and satisfaction in greater detail. This design
would allow comparison of the saved cost of an
avoided visit against the cost of any potential
increase in testing.
E-consults in cardiology appear to reduce requests
for traditional visits and appear to be associated
with high levels of patient and physician satisfaction.
E-consults have the potential to provide accountable
care organizations with a value-enhancingmechanism
for providing cardiology care.*Jason H. Wasfy, MD, MPhil
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Elective Chronic Total
Coronary Occlusion
Angioplasty
Analysis From the U.K. Central Cardiac
Audit DatabaseIn a recent issue of the Journal, George et al. (1)
conducted a multicenter registry study on 13,443
patients and found that, during a mean follow-up of
2.6 years, percutaneous revascularization of chronic
total occlusions (CTO) was associated with improved
long-term survival.
As correctly highlighted in the study limitation
section and in the accompanying editorial by Mah-
mud (2), there were numerous potential biases with
this retrospective observational analysis. For ex-
ample, patients with “unsuccessful” CTO were older
and had higher prevalence of other clinical risk fac-
tors, already known to adversely affect prognosis.
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2708Notwithstanding, the authors performed additional
secondary analysis and found that complete revas-
cularization (deﬁned as post-procedural obstruction
of <50% in all major epicardial coronary arteries)
conferred the best mortality outcome.
Given that we believe the labels in the central
illustration graph have been erroneously inverted
(patients undergoing successful CTO with/without
complete revascularization have higher cumulative
mortality?), in any case, these results deserve further
attention.
Indeed, despite statistical issues and the contro-
versial deﬁnition of complete revascularization,
mortality data of the complete revascularization
group (CTO and other major vessels) were quite
similar to those of patients undergoing partial revas-
cularization (only CTO), and completely overlapped
at 2.5 years. In fact, these results are in line with
previous large randomized trials, showing no clear
death or myocardial infarction beneﬁt from an initial
strategy of revascularization (3). In conclusion, in our
opinion, it appears premature to conclude that “the
improvement was greatest in patients when complete
revascularization was achieved.”*Alda Huqi, MD
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and Successful
RevascularizationGeorge et al. (1) recently published a database
review of treatment of attempted revascularization ofchronic total occlusion in the United Kingdom. They
have compiled a useful analysis of the outcomes and
feasibility of attempted revascularization of chronic
total occlusions. The paper is informative as a
descriptive study. However, analyzing mortality on
the basis of successful versus failed recanalization is
not a fair assessment of the beneﬁt of the procedure.
The analysis is performed on the basis of an outcome
variable (procedural success) rather than on an input
variable (attempted revascularization).
It is not logical to suggest that a procedure is
beneﬁcial simply because those with failed pro-
cedures had worse outcomes than those with suc-
cessful procedures. It is not surprising in any ﬁeld of
endeavor that success is associated with better
outcome than failure. One should not imply that a
cancer drug is beneﬁcial simply because patients who
responded to the drug did better than those that did
not; one cannot imply beneﬁt of revascularization
because those with successful interventions do better
than those with failed interventions.
If we are to conclude that these groups (procedural
success and procedural failure) are comparable (i.e.,
have similar disease burdens) then we should have
expected similar procedural outcomes. However,
procedural failure is more likely due to the com-
plexity of the underlying disease. It is quite likely that
the difference in mortality observed is explained by
differences in the severity of the underlying disease
or other comorbidities rather than by any beneﬁt of
the procedure.
The authors do not make any mention of the bias
introduced by inferring beneﬁt of a procedure by
comparing outcomes of failure versus success, and
Dr. Mahmud, in the accompanying editorial (2), only
brieﬂy suggests there might be an interaction
between the underlying disease and outcome. In this
setting, there is no relevant group for comparison of
revascularization beneﬁt, as there is no group that did
not have attempted revascularization. In the absence
of randomization, an alternative would be to try to
match patient with chronic occlusion who did not
undergo attempted revascularization. In any event,
to establish beneﬁt of the procedure, there must be
some comparison group that did not undergo the
procedure. In the absence of a relevant control or
comparison group, they should not suggest that the
procedure is beneﬁcial; they can only state that
failure is worse than success.
Absent relevant comparison groups, this study
stands as a very detailed description of outcomes in
a large population of subjects undergoing revas-
cularization of chronically totally occluded coronary
arteries, but it does not establish a mortality beneﬁt.
